RR

Reena Rathore

Active Director Director DIN 10622112
DIN 10622112 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Reena Rathore

Data last updated:

Reena Rathore is a Director at Rquarius Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10622112
Primary Designation Director
Industry Pharma
First Appointment 11 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 May 20242024Active

Board colleagues of Reena Rathore

NameDINCompanyDesignation
Brij Kishore10988840Rquarius Pharmaceuticals Private LimitedAdditional Director
Munna Lal10545380Rquarius Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rquarius Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reena Rathore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Rathore

Reena Rathore currently holds 1 directorship: Rquarius Pharmaceuticals Private Limited (Director, since 11 May 2024).

Reena Rathore was first appointed on 11 May 2024 as Director at Rquarius Pharmaceuticals Private Limited.

The current boards of Reena Rathore's companies include Brij Kishore (Rquarius Pharmaceuticals Private Limited), Munna Lal (Rquarius Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available